Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126366331 | 12636633 | 1 | I | 20160803 | 20160809 | 20160809 | EXP | US-PFIZER INC-2016375097 | PFIZER | 44.00 | YR | M | Y | 81.00000 | KG | 20160809 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126366331 | 12636633 | 1 | PS | ZYVOX | LINEZOLID | 1 | Intravenous (not otherwise specified) | 600 MG, 2X/DAY | 21131 | 600 | MG | SOLUTION FOR INFUSION | BID | ||||||
126366331 | 12636633 | 2 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Intravenous (not otherwise specified) | 500 MG, 1X/DAY | 0 | 500 | MG | QD | |||||||
126366331 | 12636633 | 3 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | 150 ML, UNK | 0 | 150 | ML |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126366331 | 12636633 | 1 | Sepsis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126366331 | 12636633 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126366331 | 12636633 | Drug dose omission | |
126366331 | 12636633 | Product use issue | |
126366331 | 12636633 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |